公开(公告)号：US09844552B2

公开(公告)日：2017-12-19

申请号：US14957294

申请日：2015-12-02

Applicant: Pharmacyclics LLC

Inventor： Toni Jauset Gonzá#lez ,  Daniel Massó-Vallés ,  Laura Soucek

IPC: A61K31/519 ,  C09B31/147 ,  A61K31/7068

CPC classification number: A61K31/519 ,  A61K31/7068 ,  C09B31/147 ,  A61K2300/00

Abstract: Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).

公开(公告)号：US10226466B2

公开(公告)日：2019-03-12

申请号：US15836482

申请日：2017-12-08

Applicant: Pharmacyclics LLC

Inventor： Toni Jauset González ,  Daniel Massó-Vallés ,  Laura Soucek

IPC: A61K31/519 ,  C09B31/147 ,  A61K31/7068

Abstract: Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).

公开(公告)号：US20180153896A1

公开(公告)日：2018-06-07

申请号：US15836482

申请日：2017-12-08

Applicant: Pharmacyclics LLC

Inventor： Toni Jauset González ,  Daniel Massó-Vallés ,  Laura Soucek

IPC: A61K31/519 ,  C09B31/147 ,  A61K31/7068

CPC classification number: A61K31/519 ,  A61K31/7068 ,  C09B31/147 ,  A61K2300/00

Abstract: Disclosed are methods of treating fibrosis in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of an ACK inhibitor (e.g., a BTK inhibitor, such as for example an irreversible BTK inhibitor, such as for example, ibrutinib).